|
V.GRAT
|
As the battery manufacturing industry becomes increasingly competitive, many...
|
|
V.GRAT
|
Gratomic Inc. announces that it is in the process of submitting 243 Kg of...
|
|
C.QNTM
|
FSD Pharma Inc. (NASDAQ: HUGE), which is based in Toronto but has its senior...
|
|
C.QNTM
|
The new drug candidate, FSD201, is being developed to address the "over...
|
|
C.QNTM
|
FSD Pharma this year transitioned from a focus on medical marijuana...
|
|
C.QNTM
|
The primary objective of the study is to determine whether FSD201 plus the...
|
|
C.QNTM
|
The primary objective of the FSD201 COVID-19 Trial is to determine whether...
|
|
C.QNTM
|
The FSD201 COVID-19 Trial is a randomized, controlled, double-blind...
|
|
C.QNTM
|
The Phase 1 first-in-human safety and tolerability study with ultramicronized...
|
|
C.QNTM
|
The Company filed a pre-IND meeting request package with the U.S. Food and...
|
|
C.QNTM
|
In Q220, the Company continued to strengthen available cash on hand through...
|
|
C.QNTM
|
The Company recently announced a US $20M at-the-market offering, the closing...
|
|
C.QNTM
|
FSD Pharma continues to grow! (in more ways that one) This week, the FSD...
|
|
C.QNTM
|
FSD Pharma Inc., a specialty, biotech pharmaceutical R&D company, focused...
|
|
C.QNTM
|
The Company has also agreed to issue common share purchase warrants to...
|
|
C.QNTM
|
FSD Pharma announces the closing of a previously announced private placement...
|
|
C.QNTM
|
FSD Pharma announced that it has notified Health Canada of the Company’s...
|
|
C.QNTM
|
CEO and Chairman, Raza Bokhari speaks about the company's lead Compound...
|
|
C.QNTM
|
The offering has been made pursuant to an effective shelf registration...
|
|
C.QNTM
|
CEO Raza Bokhari tells Proactive it has closed US$10 million in a registered...
|